Wragge & Co advises Matrix Private Equity on the management buy-out of EMaC Limited

Wragge & Co's Private Equity team has advised Matrix Private Equity Partners on its £6 million investment to support the management buy-out of EMaC Limited. The UK car service plan provider EMaC has been acquired from Hardy Mill Holdings Limited for an undisclosed sum.

Wragge & Co advises H2 Equity Partners on acquiring a majority share in Unipart Automotive

Wragge & Co has advised private equity firm H2 Equity Partners on its acquisition of a majority share in automotive car part supplier Unipart Automotive for an undisclosed sum.

Wragge & Co boosts Paris office with two director hires

Wragge & Co has strengthened its Paris office with the appointment of two directors.

Wragge & Co acts for Lyceum Capital on Adapt investment

Wragge & Co's Corporate team has advised Lyceum Capital on its £30 million acquisition of independent managed IT services provider Adapt. The deal secures backing for Adapt's expansion strategy through organic and acquisitive growth.

Wragge & Co advises NVM Private Equity and Tinglobal Holdings Ltd on management buy-out

Wragge & Co's Corporate group has advised NVM Private Equity and Tinglobal Holdings Ltd on the management buy-out of Tinglobal Limited - a specialist in the refurbishment and sale of mid-to-high end IT infrastructure and related services.

Wragge & Co advises on sale of Phones 4u

Wragge & Co's Corporate group has advised the management team on the sale of Phones 4u to private equity house BC Partners. US-based Providence Equity and the Phones 4u management team sold the mobile phone retailer for an undisclosed sum.

Wragge & Co advises ISIS on the £10 million sale of Credit Solutions

Wragge & Co advises LDC on Mountain Warehouse group acquisition

Wragge & Co has advised Lloyds TSB Development Capital (LDC) on the acquisition of the Mountain Warehouse group - one of the UK's largest retailers of outdoor clothing and equipment.

Wragge & Co expands corporate practice with two director appointments

Wragge & Co has boosted its corporate capabilities with the promotion of Gareth Baker and Richard Goold to director.

Paris office now open

Wragge & Co's new Paris office is now open, offering commercial legal advice from some of France's leading lawyers. A substantial new office in Paris adds serious strength to Wragge & Co's international capabilities.

Wragge & Co boosts City credentials with partner hire

Wragge & Co LLP has appointed a new partner, enhancing its corporate finance and private equity capability. David Marshall has joined from Travers Smith; the first in a series of new hires to expand Wragge & Co's City-based corporate practice.

Wragge & Co Public Companies team advises Conygar on hostile public takeover

Wragge & Co LLP Equity Markets team has advised AIM listed property company, The Conygar Investment Company Plc, on its successful hostile reverse takeover of London and Channel Islands listed company, the Advantage Property Income Trust Limited (TAP).

Wragge & Co advises Lloyds TSB Development Capital on MBO

Wragge & Co LLP's Corporate group has advised Lloyds TSB Development Capital Limited on an £11 million management buy-out.

Wragge & Co advises Chroma Therapeutics on billion dollar deal double

Wragge & Co LLP's cross-firm life sciences practice has advised biotechnology company Chroma Therapeutics Limited on two simultaneous transactions completed in one day.

Wragge & Co advises the management of SLR Holdings Limited on a major investment by 3i

Wragge & Co LLP Private Equity team has advised the shareholders and management of SLR Holdings (SLR) on a major investment by 3i. The investment will fund the next phase of environmental consultancy SLR's international expansion.

Wragge & Co advises on £30 million sale

Wragge & Co LLP Private Equity team has advised the shareholders of Product Support Holdings Limited (PSHL), including NVM Private Equity, on the £30 million sale of PSHL to Wincanton.

Wragge & Co Life Sciences team advises Astex on $500 million drug discovery alliance

Wragge & Co LLP Life Sciences team has advised Astex Therapeutics Limited on a landmark $500 million drug discovery alliance with Janssen Pharmaceutica N.V.

Wragge & Co Private Equity team advises NVM on telecomms MBO

Wragge & Co LLP Private Equity team has advised NVM Private Equity Limited (NVM) on its £5 million investment in the management buy-out of Optilan Ltd. Additional bank funding was provided by Allied Irish Bank and GE Capital.

Wragge & Co LLP advises Lloyds TSB Development Capital on £40 million deal

Wragge & Co LLP Private Equity team has advised Lloyds TSB Development Capital on its £40 million investment in GVA Grimley LLP.

Wragge & Co completes £46.5 million Protocol Skills MBO for Close Brothers

Wragge & Co advises Octopus on a £12 million acquisition deal

Wragge & Co LLP's Private Equity Team has advised Octopus Investments on a £12 million acquisition of restaurant group Smollenskys and the Pastiche Bistros and Le Frog Bistros brands.

Wragge & Co advises NVM Private Equity on £17.5 million buyout of Astbury Marsden

Private equity partner Ian Piggin led a cross-firm team assisted by associate Jonathan Tilley, tax partners Neil Pearson and Kevin Lowe, banking and finance partner Kirsty Barnes and director Chris Gayle.